Клинически важные последствия одновременной блокадырецепторов ангиотензина II и активацииPPAR-γтелмиcартаном
Клинически важные последствия одновременной блокадырецепторов ангиотензина II и активацииPPAR-γтелмиcартаном
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Benson SC, Pershadsingh HA, Ho CI et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR -modulating activity. Hypertension 2004; 43: 993–1002.
2. Yamagishi S, Takeuchi M. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-g-inducing property. Med Hypotheses 2005; 64: 476–8.
3. Mallion JM, Siche JP, Lacourciere Y et al. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens 1999; 13: 657–64.
4. Derosa G et al. Effects of Telmisartan Compared with Eprosartan on Blood Pressure Control Hypertens Res 2004; 27: 457–64.
5. Miura Y et al. Metabolic Effects of Replacing Valsartan or Candesartan by Telmisartan Diabetes Care 2005; 28: 757–8.
6. Sugimoto K, Qi NR, Kazdova L et al. Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis. Hypertension 2006; 47: 1003–9.
2. Yamagishi S, Takeuchi M. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-g-inducing property. Med Hypotheses 2005; 64: 476–8.
3. Mallion JM, Siche JP, Lacourciere Y et al. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens 1999; 13: 657–64.
4. Derosa G et al. Effects of Telmisartan Compared with Eprosartan on Blood Pressure Control Hypertens Res 2004; 27: 457–64.
5. Miura Y et al. Metabolic Effects of Replacing Valsartan or Candesartan by Telmisartan Diabetes Care 2005; 28: 757–8.
6. Sugimoto K, Qi NR, Kazdova L et al. Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis. Hypertension 2006; 47: 1003–9.
Авторы
С.В.Недогода, В.В.Цома, Т.А.Чаляби, А.А.Ледяева
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.